The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Dalmapam 15mg Hard Capsules



Pinewood Laboratories Ltd,PA0281/073/001

Main Information

Trade NameDalmapam 15mg Hard Capsules
Active SubstancesFlurazepam
Dosage FormCapsule, hard
Licence HolderPinewood Laboratories Ltd,
Licence NumberPA0281/073/001

Group Information

ATC CodeN05CD Benzodiazepine derivatives
N05CD01 flurazepam

Status

License statusWithdrawn
Withdrawn Date22/02/2021
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable ListFlurazepam 15mg Capsules
Interchangeable List CodeIC0093-032-001
Interchangeable List DocumentPDF of Interchangeable List
« Back